The expected dose for the standard 50/10/10 milligram GLOW blend lands in the range of 250 to 600 micrograms of BPC-157 daily, with proportional GHK-Cu and TB-500
No blinding was performed
Seppnen K, Kantola M, Laatikainen R, et al
Today we know this medication under the brand name Wegovy, which is prescribed at a higher dose to treat obesity
Most users notice initial improvements in two to four weeks
However, such results must be interpreted cautiously, as the small sample size and short study durations preclude comment on the long-term effects and safety of GLP-1 RAs in the treatment of psoriasis, ultimately limiting the ability to draw definitive, robust conclusions